In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

PhotoThera gets $50mm through its Series D round

Executive Summary

PhotoThera (stroke therapy) has raised $50mm through the closing of its Series D venture round. Warburg Pincus led the financing and was joined by fellow existing backers Vertical Group, Hamilton BioVentures, Delphi Ventures, DeNovo Ventures, Solstice Capital, and members of Monterey Advisors. PhotoThera will use the proceeds to fund a redesigned Phase III trial of NeuroThera--an infrared laser to noninvasively treat ischemic stroke--because its last study did not meet primary endpoints. The company has brought in over $100mm to date.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Laser
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies